interesting article from mergermarket, page-7

Hi locky27.

My understanding of the new R&D tax rebate is that a Company can now claim a Tax credit on any of it's expenses related to R&D. I would imagine that the costs in regard to the Cvac testing program would be considered an R&D activity. I don't see that there is a benefit as far as tax credits are concerned to shareholdersin filing their tax return. The only benefit I see to shareholders is that a shareholder who holds shares in a company undertaking R&D will benefit by the fact the Company can write off income etc against this R&D tax benefit, hence giving a "better" balance sheet for the end of year financial report.

Perhaps there is an accountant out there who could probably explain the R&D tax credit as it applies to PRR.

Thanks for your querry. I am an advocate of always asking questions to satisfy ones understanding of a particular matter.

Cheers
Good luck to all